Search results

• Bufotenin
  administered bufotenin undergoes extensive first-pass metabolism by the enzyme monoamine oxidase. Bufotenin's psychedelic effects are primarily believed to come
  16 KB (2,273 words) - 19:54, 7 April 2024
• 2C-T-2 (category PsychonautWiki articles needing factual verification from October 2020)
  the 2,5-desmethoxy derivative of 2C-T-7) are known to act as selective monoamine oxidase A inhibitors.[citation needed] Furthermore, many compounds of the
  22 KB (2,627 words) - 23:08, 29 May 2021
• Methylone
  transporters is similar. Notably, methylone's affinity for the vesicular monoamine transporter 2 (VMAT2) is about 13x lower than that of MDMA. The result
  19 KB (2,841 words) - 14:21, 16 April 2024
• 4F-EPH
  produces long-lasting euphoric and stimulating effects associated with potent monoamine reuptake inhibitors when administered. It is a closely related structural
  17 KB (2,757 words) - 17:49, 30 July 2022
• Rolicyclidine
  (PsychonautWiki) | https://psychonautwiki.org/wiki/3-MeO-PCP#Toxicity_and_harm_potential PCP Psychosis (PsychonautWiki) | https://psychonautwiki.org/wiki/3-M
  21 KB (2,634 words) - 00:21, 11 December 2023
• 3-FEA
  have characterised 3-FEA as a moderately potent serotonin-dominant triple monoamine releaser that produces a mixture of entactogenic and mild stimulating effects
  19 KB (3,317 words) - 15:23, 30 July 2022
• DET
  ingested along with an inhibitor of monoamine oxidase. Because DET has ethyl groups attached to its nitrogen atom, monoamine oxidase is unable to degrade it
  14 KB (1,584 words) - 04:58, 30 June 2022
• 6-APDB
  6-APB and broadly shares the characteristics of serotonin-selective triple monoamine releasers and reuptake inhibitors associated with other entactogenic or
  26 KB (4,015 words) - 23:44, 21 April 2024
• 4F-MPH
  substances are believed to have very similar pharmacological mechanisms as monoamine reuptake inhibitors but have been reported to display distinctive subjective
  16 KB (2,465 words) - 15:45, 9 May 2024
• Ethylphenidate
  ethanol transesterification metabolite ethylphenidate: brain disposition, monoamine transporters and motor activity". Behavioural Pharmacology. 18 (1): 39–51
  18 KB (2,561 words) - 14:02, 16 April 2024
• Melatonin
  next day. Melatonin is comprised of a monoamine chain attached to an indole ring at the third carbon. A monoamine chain is made up of an amine group attached
  15 KB (1,896 words) - 23:12, 21 April 2024
• Scientific information
  SNRI Synthetic cannabinoids Vagus nerve Hormone Neuron Neurotransmitter Monoamine Receptor Synapse Blood–brain barrier Serotonin Dopamine Glutamate NMDA
  599 bytes (162 words) - 23:00, 21 April 2024
• Aniracetam
  (June 1988). "[Effect of centrophenoxine, piracetam and aniracetam on the monoamine oxidase activity in different brain structures of rats]". Farmakologiia
  11 KB (1,427 words) - 22:01, 24 January 2024
• Cocoa
  dependence and withdrawals have been documented. monoamine oxidase inhibitors or reversible inhibitors of monoamine oxidase could potentially boost the actions
  10 KB (1,095 words) - 23:12, 9 May 2024
• 5-MeO-DMT
  any substance which acts as a releasing agent or reuptake inhibitor of monoamine neurotransmitters. 5-MeO-DMT is O-demethylated by polymorphic cytochrome
  26 KB (3,619 words) - 19:56, 7 April 2024
• 5-MAPB
  eISSN 1937-6995. ISSN 1556-9039. OCLC 163567183.  Gillman, P. K. (2005). "Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity". British
  13 KB (2,233 words) - 00:32, 31 December 2022
• Dichloropane
  transporter. This substance acts as a triple reuptake inhibitor and prevents monoamine neurotransmitters from being recycled, causing excessive amounts to build
  20 KB (2,747 words) - 00:19, 1 August 2022
• Cyclazodone
  damage in children. In rodents and primates, sufficiently high doses of monoamine releasing agents cause dopaminergic neurotoxicity, or damage to dopamine
  19 KB (2,675 words) - 16:54, 31 March 2024
• 3-FMA
  far characterized 3-FMA as a moderately potent serotonin-dominant triple monoamine releaser (or reuptake inhibitor) that produces a relatively short-lived
  14 KB (2,687 words) - 15:28, 30 July 2022
• 2-Aminoindane
  eISSN 1937-6995. ISSN 1556-9039. OCLC 163567183.  Gillman, P. K. (2005). "Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity". British
  12 KB (1,928 words) - 23:42, 21 April 2024

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)